sorbitol has been researched along with bupivacaine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Choi, BH; Choi, MJ; Eun, SY; Kim, HJ; Kim, KN; Lee, SH; Ok, SH; Park, CS; Shin, IW; Sohn, JT; Yang, SM | 1 |
Ahrens, J; de la Roche, J; Foadi, N; Koppert, W; Lampert, A; Leffler, A; Nadrowitz, F; Stoetzer, C; Wegner, F | 1 |
5 other study(ies) available for sorbitol and bupivacaine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effect of two lipid emulsions on reversing high-dose levobupivacaine-induced reduced vasoconstriction in the rat aortas.
Topics: Animals; Aorta, Thoracic; Bupivacaine; Drug Combinations; Emulsions; Fat Emulsions, Intravenous; Human Umbilical Vein Endothelial Cells; Humans; Levobupivacaine; Male; Organ Culture Techniques; Phospholipids; Rats; Rats, Sprague-Dawley; Sorbitol; Soybean Oil; Treatment Outcome; Vasoconstriction | 2013 |
The distinct effects of lipid emulsions used for "lipid resuscitation" on gating and bupivacaine-induced inhibition of the cardiac sodium channel Nav1.5.
Topics: Absorption; Anesthetics, Local; Bupivacaine; Dose-Response Relationship, Drug; Drug Combinations; Electrophysiology; Emulsions; Fat Emulsions, Intravenous; HEK293 Cells; Humans; Inhibitory Concentration 50; Kidney; Lipids; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Phospholipids; Sodium Channel Blockers; Sorbitol; Soybean Oil | 2013 |